Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
Journal of Hematology & Oncology|August 29, 2025
Recent advances in universal chimeric antigen receptor T cell therapyNing Jiang, Zhaoyi Yang, Huilei Miao, et al.Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 15, 2021
Inherited ichthyosis and fungal infection: an update on pathogenesis and treatment strategiesHuilei Miao, Ruijia Dong, Shiyu Zhang, et al.Medicine|April 28, 2021
Association between serum uric acid and bone mineral density in patients with type 2 diabetes: A 6-year longitudinal study in ChinaKun Yang, Huilei Miao, Ruijie Zhao, et al.Pediatric Rheumatology Online Journal|January 7, 2021
Type I interferonopathies with novel compound heterozygous TREX1 mutations in two siblings with different symptoms responded to tofacitinibShiyu Zhang, Jiaxing Song, Yuyan Yang, et al.Thoracic Cancer|April 5, 2024
Quantitative evaluation of the impact of relaxing eligibility criteria on the risk-benefit profile of drugs for lung cancer based on real-world dataHuiyao Huang, Shuopeng Jia, Xin Wang, et al.Journal of the National Cancer Center|July 22, 2024
Advances on anticancer new drugs in China and the USA in 2020: from ongoing trial to drug approvalHuiyao Huang, Huilei Miao, Jun Wang, et al.Journal of Hematology & Oncology|February 9, 2022
The global landscape of neoadjuvant and adjuvant anti-PD-1/PD-L1 clinical trialsDawei Wu, Huiyao Huang, Minghui Zhang, et al.Cancer Letters|October 24, 2022
Drug conjugate-based anticancer therapy - Current status and perspectivesYuqi Yang, Shuhang Wang, Peiwen Ma, et al.Journal of Cancer Research and Clinical Oncology|January 20, 2023
HLA and tumour immunology: immune escape, immunotherapy and immune-related adverse eventsNing Jiang, Yue Yu, Dawei Wu, et al.Frontiers in Molecular Biosciences|April 1, 2022
KRAS Mutation in Rare Tumors: A Landscape Analysis of 3453 Chinese PatientsShuhang Wang, Qin Li, Peiwen Ma, et al.Pageof 3